Article Text

PDF
Original article
Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma
  1. Astrid van Huisstede1,
  2. Arjan Rudolphus1,
  3. Manuel Castro Cabezas2,
  4. Laser Ulas Biter3,
  5. Gert-Jan van de Geijn4,
  6. Christian Taube5,
  7. Pieter S Hiemstra5,
  8. Gert-Jan Braunstahl1
    1. 1Department of Pulmonology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    2. 2Department of Internal Medicine, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    3. 3Department of Surgery, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    4. 4Department of Clinical Chemistry, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
    5. 5Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
    1. Correspondence to Astrid van Huisstede, Department of Pulmonology, Sint Franciscus Gasthuis, Kleiweg 500, Rotterdam 3045 PM, The Netherlands; a.vanhuisstede{at}sfg.nl

    Abstract

    Background The pathogenesis of asthma in obese subjects is poorly understood and has been described as a specific phenotype in these patients. Weight loss improves asthma control and lung function. Whether this improvement is the result of better mechanical properties of the airways or decreased systemic and bronchial inflammation remains unclear.

    Methods A longitudinal study in obese patients with asthma (bariatric surgery and asthma group (BS+A), n=27) and obese control (bariatric surgery without asthma group (BS−A), n=39) subjects undergoing bariatric surgery, and obese patients with asthma without intervention (no bariatric surgery and asthma group (NBS+A), n=12). Lung function, asthma control, cellular infiltrates in bronchial biopsies and circulating markers of systemic inflammation were measured during follow up at 3, 6 and 12 months.

    Results Bariatric surgery resulted in a profound weight loss at 12 months. In the BS+A group as well as the BS−A group FEV1, functional residual capacity, total lung capacity improved, whereas FEV1/FVC only improved in the BS−A group. In addition, Asthma Control Questionnaire (ACQ), Asthma Quality of Life Questionnaire, inhaled corticosteroid use and PD20 improved in BS+A, whereas in the NBS+A group only ACQ improved. Small airway function R5–R20 improved in both surgery groups, however the change in the BS+A group was greater, resulting in a comparable R5–R20 between BS+A and BS−A at 12-month follow-up. Besides improvement of systemic inflammation (high sensitivity C-reactive protein, adiponectin and leptin) after BS, only a decrease in mast cell numbers was detectable in the BS+A group.

    Conclusions Bariatric surgery improved small airway function, decreased systemic inflammation and number of mast cells in the airways. These effects could explain the improvement of asthma control, quality of life and lung function. Therefore bariatric surgery, in addition to all other positive effects, also improves asthma in subjects with morbid obesity.

    Trial registration number 3204.

    • Asthma
    • Asthma Mechanisms
    • Bronchoscopy

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.